Zobrazeno 1 - 10
of 671
pro vyhledávání: '"Ripoll, Vera"'
Publikováno v:
Medicina Clínica Práctica, Vol 7, Iss 4, Pp 100450- (2024)
Externí odkaz:
https://doaj.org/article/ac0349074bf7423f9f6c08b11d775ce7
Autor:
García-Izquierdo, Eusebio, Scrocco, Chiara, Palacios-Rubio, Julián, Assaf, Amira, Ripoll-Vera, Tomás, Hernandez-Betancor, Iván, Ramos-Ruiz, Pablo, Melero-Pita, Antonio, Segura-Domínguez, Melodie, Jiménez-Sánchez, Diego, Castro-Urda, Victor, Toquero-Ramos, Jorge, Yap, Sing-Chien, Behr, Elijah R., Fernández-Lozano, Ignacio
Publikováno v:
In Heart Rhythm August 2024 21(8):1317-1324
Autor:
Viana Tejedor, Ana, Ripoll-Vera, Tomás, Bravo Amaro, María Sol, Ariza-Solé, Albert, Sandín Rollán, Miriam, Vivas Balcones, David, Romero Rodríguez, Nieves, Fernández Olmo, María Rosa
Publikováno v:
In REC: CardioClinics July-September 2024 59(3):201-211
Autor:
Aina Gayà-Barroso, Juan González-Moreno, Adrián Rodríguez, Tomás Ripoll-Vera, Inés Losada-López, Margarita Gili, Milena Paneque, Sara Pérez-Martínez, Eugenia Cisneros-Barroso
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-8 (2023)
Abstract Background Hereditary transthyretin amyloidosis (ATTRv) is a rare genetic disease that negatively affects patients' quality of life through the involvement of various organs and tissues. Despite a large amount of research on medical and psyc
Externí odkaz:
https://doaj.org/article/7ecaeaeaa59e4f45be8fb91e15e07268
Autor:
E. Cisneros-Barroso, F. Gorram, M. A. Ribot-Sansó, F. Alarcon, G. Nuel, J. González-Moreno, A. Rodríguez, J. Hernandez-Rodriguez, E. Amengual-Cladera, I. Martínez-López, T. Ripoll-Vera, I. Losada-López, D. Heine-Suñer, V. Plante-Bordeneuve
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-7 (2023)
Abstract Background Variant transthyretin amyloidosis (A-ATTRv) is an autosomal dominant disease caused by a range of TTR gene variants which entail great phenotypical heterogeneity and penetrance. In Majorca, the A-ATTRv caused by the V30M gene vari
Externí odkaz:
https://doaj.org/article/3501c5edd17945e8bf02f9ed4ad5383c
Autor:
Rocío Blanco, Yolanda Rico-Ramírez, Álvaro Hermida-Ameijeiras, Israa Mahmoud Sanad Abdullah, Kolja Lau, Jorge Alvarez-Rubio, Elena Fortuny, Amparo Martínez-Monzonís, Albina Nowak, Peter Nordbeck, Carlos Veras-Burgos, Jaume Pons-Llinares, Emiliano Rossi, Fiama Caimi-Martínez, Teresa Bosch-Rovira, Marta Alamar-Cervera, Virginia Ruiz-Pizarro, Laura Torres-Juan, Damian Heine-Suñer, Tomás Ripoll-Vera
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 8, p 4299 (2024)
The p.Arg301Gln variant in the α -galactosidase A gene (GLA) has been poorly described in the literature. The few reports show controversial information, with both classical and nonclassical Anderson–Fabry Disease (AFD) presentation patterns. The
Externí odkaz:
https://doaj.org/article/2f0e8a45e1a5487b9b0ecaab22b81f0c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Rosario Sánchez, Tomás Ripoll-Vera, Manuel López-Mendoza, Joaquín de Juan-Ribera, Juan Ramón Gimeno, Álvaro Hermida, María Aurora Ruz-Zafra, José Vicente Torregrosa, Antonia Mora, José Manuel García-Pinilla, Elena Fortuny, Ana Aguinaga-Barrilero, Roser Torra
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Background Fabry disease (FD) is an X-linked condition caused by variants in the GLA gene. Since females have two X chromosomes, they were historically thought to be carriers. Although increased knowledge has shown that females often develop
Externí odkaz:
https://doaj.org/article/97d9b7378eee421696d9ada54b59aa94
Autor:
Jiménez-Jáimez, Juan, Villacorta, Eduardo, Zorio-Grima, Esther, Ripoll-Vera, Tomás, Macías-Ruiz, Rosa, Bermúdez-Jiménez, Francisco, Limeres-Freire, Javier
Publikováno v:
In REC: CardioClinics January 2023 58 Supplement 1:S68-S73
Autor:
Juan R. Gimeno, Iacopo Olivotto, Ana Isabel Rodríguez, Carolyn Y. Ho, Adrián Fernández, Alejandro Quiroga, Mari Angeles Espinosa, Cristina Gómez‐González, María Robledo, Lucas Tojal‐Sierra, Sharlene M. Day, Anjali Owens, Roberto Barriales‐Villa, Jose María Larrañaga, Jose Rodríguez‐Palomares, Maribel González‐del‐Hoyo, Jesús Piqueras‐Flores, Nosheen Reza, Olga Chumakova, Euan A. Ashley, Victoria Parikh, Matthew Wheeler, Daniel Jacoby, Alexandre C. Pereira, Sara Saberi, Adam S. Helms, Eduardo Villacorta, María Gallego‐Delgado, Daniel deCastro, Fernando Domínguez, Tomás Ripoll‐Vera, Esther Zorio‐Grima, José Carlos Sánchez‐Martínez, Ana García‐Álvarez, Elena Arbelo, María Victoria Mogollón, María Eugenia Fuentes‐Cañamero, Elias Grande, Carlos Peña, Lorenzo Monserrat, Neal K. Lakdawala, Dilema International Cardiomyopathy and Heart Failure Registry and international SHaRe (Sarcomeric Human Cardiomyopathy Registry) Investigators group
Publikováno v:
ESC Heart Failure, Vol 9, Iss 4, Pp 2189-2198 (2022)
Abstract Aims To describe the natural history of SARS‐CoV‐2 infection in patients with hypertrophic cardiomyopathy (HCM) compared with a control group and to identify predictors of adverse events. Methods and results Three hundred and five patien
Externí odkaz:
https://doaj.org/article/91483f6a810740f68b374d86c8670633